SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001346302-20-000042
Filing Date
2020-06-29
Accepted
2020-06-26 20:35:18
Documents
21
Period of Report
2020-06-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xers-20200626.htm   iXBRL 8-K 78908
2 EX-1.1 exh11equityunderwritin.htm EX-1.1 316156
3 EX-1.2 exh12convertibledebtun.htm EX-1.2 327675
4 EX-5.1 exh51opinionofgoodwinp.htm EX-5.1 7731
5 EX-5.2 exh52opinionofgoodwinp.htm EX-5.2 15928
6 EX-99.1 exh9912020launchpressr.htm EX-99.1 14700
7 EX-99.2 exh9922020pricingpress.htm EX-99.2 18871
13 xerislpharmrgba111.jpg GRAPHIC 74582
  Complete submission text file 0001346302-20-000042.txt   1202207

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xers-20200626.xsd EX-101.SCH 2420
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xers-20200626_cal.xml EX-101.CAL 708
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xers-20200626_def.xml EX-101.DEF 15623
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xers-20200626_lab.xml EX-101.LAB 30040
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xers-20200626_pre.xml EX-101.PRE 16292
18 EXTRACTED XBRL INSTANCE DOCUMENT xers-20200626_htm.xml XML 11488
Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Filer) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38536 | Film No.: 20995675
SIC: 2834 Pharmaceutical Preparations